Sat.Mar 16, 2024

article thumbnail

ScienceSaturday: March 16, 2024

KIF1A

#ScienceSaturday posts share exciting scientific developments and educational resources with the KAND community. Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. KIF1A-Related Research Whole genome sequencing increases the diagnostic rate in Charcot-Marie-Tooth disease Charcot-Marie-Tooth (CMT) disease is an inherited disorder that causes degeneration of motor and sensory neuro

Disease 105
article thumbnail

How to Check Your Home for Bedbugs

Drugs.com

SATURDAY, March 16, 2024 -- Nothing can spoil a vacation's sweet afterglow more than discovering that some unwelcome hitchhikers have accompanied you home.Bedbugs — tiny, reddish-brown insects that feed on blood — are notorious luggage.

105
105
article thumbnail

Which pharmaceutical drugs have the most drug patents in Colombia?

Drug Patent Watch

This chart shows the drugs with the most patents in Colombia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.

Drugs 59
article thumbnail

New tentative approval for Zydus Pharms drug empagliflozin;linagliptin;metformin hydrochloride

Drug Patent Watch

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

New tentative approval for Sandoz Inc drug rifaximin

Drug Patent Watch

Rifaximin is the generic ingredient in one branded drug marketed by Salix Pharms and is included in one NDA. There are twenty-nine patents protecting this compound.

Drugs 59